Écrit par WHO			
				
			|	
						
				02 Septembre 2016			
			
				
		
				
				
		 2 September 2016 - The fourth meeting of the Emergency Committee (EC) on Zika and  microcephaly convened by the Director-General under the International  Health Regulations (2005) regarding microcephaly, other neurological  disorders and Zika virus was held by teleconference on 1 September 2016,  from 13:15 to 15:45 Central European Time.
2 September 2016 - The fourth meeting of the Emergency Committee (EC) on Zika and  microcephaly convened by the Director-General under the International  Health Regulations (2005) regarding microcephaly, other neurological  disorders and Zika virus was held by teleconference on 1 September 2016,  from 13:15 to 15:45 Central European Time.
 The Committee was briefed on the implementation of the Temporary  Recommendations issued by the Director-General on advice from the three  previous EC meetings. The Committee was updated on the situation during  and after the Olympic Games held in Brazil, the latest developments on  Zika virus geographic spread, natural history, epidemiology,  microcephaly and other neonatal complications associated with Zika  virus, Guillain-Barré syndrome (GBS) and current knowledge on sexual  transmission of Zika virus. 
 
 The following States Parties provided information on microcephaly, GBS  and other neurological disorders occurring in the presence of Zika virus  transmission as well as control measures being implemented: Brazil, the  United States of America and Singapore.
 
 The Committee congratulated Brazil on their successful application of  appropriate public health measures during the Olympic Games. To date,  there have been no reports of confirmed cases of Zika virus among people  who attended the Games, both during the games and since their return.  The lack of cases supports the conclusions of the risk assessment  regarding the Olympic Games made during the 3rd EC meeting.
 
 Having considered the evidence presented, the Committee agreed that due  to continuing geographic expansion and considerable gaps in  understanding of the virus and its consequences, Zika virus infection  and its associated congenital and other neurological disorders continues  to be a Public Health Emergency of International Concern (PHEIC). 
 
 The Committee restated the advice it provided to the Director-General  in its previous meetings in the areas of public health research on  microcephaly, other neurological disorders and Zika virus, surveillance,  vector control, risk communications, clinical care, travel measures,  research and product development related to vaccines, therapeutics, and  laboratory tests. The Committee noted that activities based on this  advice remain in place and are all being implemented. The Committee also  reaffirmed its previous advice that there should be no general  restrictions on travel and trade with countries, areas and/or  territories with Zika virus transmission, including the cities in Brazil  that will be hosting the Paralympic Games. 
 
 Furthermore, acknowledging that the impact of Zika virus is a long term  concern, the Committee recommended that the Director General considers  developing an appropriate infrastructure and response plan within the  World Health Organization to provide longer term coordination and  accountability for ensuring an effective response.
 The Committee emphasized the need for a better scientific understanding  of Zika virus epidemiology, clinical disease, and prevention with  recommended several new research issues, and re-emphasised several  research issues made previously, in order to:
 ·Â Â Â Â Â Â Â Â  enhance understanding of the different viral lineages,  including cross reactivity and cross-immunity between them as well as  their clinical implications
 ·Â Â Â Â Â Â Â Â  assess possible co-factors or risk factors that might impact disease severity
 ·Â Â Â Â Â Â Â Â  better understand the natural history of the disease in  children who are congenitally infected, pregnant women, and other  children and adults
 ·Â Â Â Â Â Â Â Â  determine length and location of viral persistence in humans, and its impact on transmissibility
 ·Â Â Â Â Â Â Â Â  better establish the risk of infection and modes of transmission
 ·Â Â Â Â Â Â Â Â  assess the utility of effective vector control tools and their operational feasibility
 ·Â Â Â Â Â Â Â Â  continue development of safe and effective prevention measure (e.g., vaccine)
 
 Recognizing the impact that Zika virus disease and its consequences will  have on weak health systems, the Committee also recommended that WHO  provide appropriate guidance on effective surveillance and management of  Zika virus disease in countries with high vulnerability, low capacity.  
 
 Based on this advice, the Director-General declared the continuation of  the Public Health Emergency of International Concern (PHEIC).  The  Director-General reissued the Temporary Recommendations from the 2nd and the 3rd meeting of the Committee, endorsed the additional advice from the  Committee’s 4th meeting, and issued them as Temporary Recommendations  under the IHR (2005).  The Director-General thanked the Committee  Members and Advisors for their advice. The Committee will reconvene in 3  months.